IN2012DN00862A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00862A IN2012DN00862A IN862DEN2012A IN2012DN00862A IN 2012DN00862 A IN2012DN00862 A IN 2012DN00862A IN 862DEN2012 A IN862DEN2012 A IN 862DEN2012A IN 2012DN00862 A IN2012DN00862 A IN 2012DN00862A
- Authority
- IN
- India
- Prior art keywords
- ring
- present
- provides
- lactone
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23288609P | 2009-08-11 | 2009-08-11 | |
US23288009P | 2009-08-11 | 2009-08-11 | |
PCT/US2010/045121 WO2011019789A1 (en) | 2009-08-11 | 2010-08-11 | The ring opening of lactones and lactams |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00862A true IN2012DN00862A (ru) | 2015-07-10 |
Family
ID=42813428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN862DEN2012 IN2012DN00862A (ru) | 2009-08-11 | 2010-08-11 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8779198B2 (ru) |
EP (1) | EP2464623B1 (ru) |
JP (1) | JP5746696B2 (ru) |
KR (1) | KR101755052B1 (ru) |
CN (1) | CN102686556A (ru) |
AU (1) | AU2010282623B2 (ru) |
BR (1) | BR112012003255B1 (ru) |
CA (1) | CA2769186C (ru) |
IN (1) | IN2012DN00862A (ru) |
MX (3) | MX344328B (ru) |
RU (1) | RU2550691C2 (ru) |
WO (1) | WO2011019789A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2551260A1 (en) | 2011-07-28 | 2013-01-30 | Chemo Ibérica, S.A. | Chemical process for opening ring compounds |
CN102351734B (zh) * | 2011-09-05 | 2014-02-26 | 浙江普洛医药科技有限公司 | 一种阿利克仑的制备方法 |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
CN108940117B (zh) * | 2018-08-03 | 2020-07-24 | 郑州轻工业学院 | 一种含羟基联接基团的非离子糖基型双子表面活性剂及其制备方法 |
CN110452231B (zh) * | 2019-08-16 | 2023-03-28 | 上海应用技术大学 | 一种色氨酸类化合物及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4729985A (en) * | 1985-08-09 | 1988-03-08 | Pfizer Inc. | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
EP0236734A3 (de) | 1986-02-07 | 1988-05-11 | Ciba-Geigy Ag | Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate |
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US20060154926A1 (en) * | 2002-06-11 | 2006-07-13 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease using aryl alkanoic acid amides |
EP1689702B1 (en) * | 2003-11-26 | 2013-01-30 | Novartis AG | Organic compounds |
GB0419361D0 (en) * | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
GB0511686D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
GB0521083D0 (en) * | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
GB0605780D0 (en) * | 2006-03-22 | 2006-05-03 | Syngenta Ltd | Formulations |
CN101679213A (zh) * | 2007-04-03 | 2010-03-24 | 诺瓦提斯公司 | 新方法 |
-
2010
- 2010-08-11 WO PCT/US2010/045121 patent/WO2011019789A1/en active Application Filing
- 2010-08-11 BR BR112012003255-0A patent/BR112012003255B1/pt not_active IP Right Cessation
- 2010-08-11 RU RU2012108932/04A patent/RU2550691C2/ru active
- 2010-08-11 MX MX2013009618A patent/MX344328B/es unknown
- 2010-08-11 MX MX2012001850A patent/MX2012001850A/es active IP Right Grant
- 2010-08-11 CN CN2010800455933A patent/CN102686556A/zh active Pending
- 2010-08-11 EP EP10744805.2A patent/EP2464623B1/en not_active Withdrawn - After Issue
- 2010-08-11 IN IN862DEN2012 patent/IN2012DN00862A/en unknown
- 2010-08-11 JP JP2012524828A patent/JP5746696B2/ja not_active Expired - Fee Related
- 2010-08-11 KR KR1020127006237A patent/KR101755052B1/ko active IP Right Grant
- 2010-08-11 AU AU2010282623A patent/AU2010282623B2/en not_active Ceased
- 2010-08-11 MX MX2013009617A patent/MX347956B/es unknown
- 2010-08-11 CA CA2769186A patent/CA2769186C/en not_active Expired - Fee Related
- 2010-08-11 US US13/389,849 patent/US8779198B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2010282623B2 (en) | 2013-12-12 |
BR112012003255B1 (pt) | 2018-10-23 |
CA2769186A1 (en) | 2011-02-17 |
MX2012001850A (es) | 2012-03-07 |
RU2550691C2 (ru) | 2015-05-10 |
KR20120054628A (ko) | 2012-05-30 |
MX347956B (es) | 2017-05-16 |
US8779198B2 (en) | 2014-07-15 |
JP2013501797A (ja) | 2013-01-17 |
AU2010282623A1 (en) | 2012-02-23 |
CN102686556A (zh) | 2012-09-19 |
EP2464623B1 (en) | 2020-11-04 |
BR112012003255A8 (pt) | 2016-05-17 |
CA2769186C (en) | 2016-10-04 |
MX344328B (es) | 2016-12-13 |
US20120165555A1 (en) | 2012-06-28 |
RU2012108932A (ru) | 2013-09-20 |
KR101755052B1 (ko) | 2017-07-06 |
WO2011019789A1 (en) | 2011-02-17 |
JP5746696B2 (ja) | 2015-07-08 |
EP2464623A1 (en) | 2012-06-20 |
BR112012003255A2 (pt) | 2016-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA110199C2 (en) | Solid rifaximin dispersion | |
TW200608973A (en) | Rapamycin polymorph Ⅱ and uses thereof | |
UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
MX342643B (es) | Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona). | |
WO2008151170A3 (en) | Process for the synthesis of ramelteon and its intermediates | |
MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
MY140739A (en) | 2, 6-quinolinyl derivatives, processes for preparing them and their uses | |
WO2011019986A3 (en) | Processes for preparing pemetrexed | |
MX2009013354A (es) | Compuestos de triarilo y composiciones que los contienen. | |
MX2011008621A (es) | Proceso para la purificacion de lipopeptidos. | |
IN2012DN02793A (ru) | ||
IN2012DN00862A (ru) | ||
TW200702331A (en) | Process for preparing alkylanilides | |
WO2009137714A3 (en) | Forms of lapatinib ditosylate and processes for preparation thereof | |
GB201303865D0 (en) | Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein | |
MX339461B (es) | Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. | |
WO2010119450A3 (en) | An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts | |
MX2009013921A (es) | Material refractario sin forma, un proceso para producir un material refractario sin forma, humedo como la tierra, y al uso del material refractario sin forma. | |
WO2010059916A3 (en) | Preparation of docetaxel | |
PL2091478T3 (pl) | Opakowanie prezerwatyw | |
MX2010003056A (es) | Polimorfos de valomaciclovir. | |
ZA200903193B (en) | Novel Morphine derivatives | |
JO2857B1 (en) | Vinyl pipers with modified activity of tumor-resistant TNF | |
MX2009006748A (es) | Proceso para la preparacion y aislamiento de los estereoisomeros individuales de fenilciclopentan-carboxilatos 3-sustituidos de 1-amino. |